Specialty Pharmacy

Numerous factors besides adherence influence effective medication management.

Various approaches needed for immunotherapy efficacy to translate into significant real world outcomes.

Alecensa found superior to crizotinib in advanced or recurrent, ALK-positive non-small cell lung cancer.

Increased gut bacteria linked to inflammation among children with multiple sclerosis.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses initiatives to optimize medication adherence.

Mutations that affect protein levels impact tumor growth.

Top news of the day from across the healthcare landscape.

Endocrinologists seek to create an observational registry so researchers can study thyroid incidentalomas systematically.

Knowing the details about new HIV diagnoses can help pharmacists better understand the infection.

Pharmacists can have a positive influence on medication adherence and several other factors in type 2 diabetes.

Drug-drug and drug-food interactions are evaluated in 58 oral chemotherapeutics.

Uneven distribution of the signaling protein c-Myc could aid the development of cancer vaccines.

The United States reduced cancer mortality by 26% overall, falling short of the 50% reduction goal set by the American Cancer Society.

Sorafenib for advanced hepatocellular carcinoma may not offer the significantly lengthened life expectancy reported in clinical trials.

Nondiscrimination in Health Programs and Activities final rule addresses discrimination and seeks to improve language barriers.

Top news of the day from across the health care landscape.

Most patients with locally advanced non-small cell lung cancer with mediastinal lymph node involvement are generally not considered good candidates for surgery.

Opdivo approved for patients with relapsed or refractory classical Hodgkin lymphoma.

NASP outlines issues with the new proposed rule for Medicare Part B.

Contracts will modify the costs of the cholesterol-lowering drugs Repatha and Praluent based on efficacy in patients.

Imbruvica approved for use in patients with chronic lymphocytic leukemia and small lymphocytic lymphoma.

Slow-binding inhibitors of cholinesterases could produce treatments for Alzheimer's disease, myasthenia, and neuroprotection.

Children found to greatly benefit from gene therapy for Leber congenital amaurosis.

Researchers found a protective effect against cancer in patients with autism spectrum disorder.

Top news of the day from across the health care landscape.

Diabetes drug interactions may decrease medication efficacy, increase toxicity, challenge adherence, and cause adverse events.

Worm infection in the gut microbiome shows promise reducing the bacterial species linked to a higher risk of IBD.

Lenvatinib with everolimus found to improve progression-free survival in RCC patients.